We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

115 hedge funds and large institutions have $858M invested in Genomic Health, Inc. in 2013 Q2 according to their latest regulatory filings, with 115 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

55% less call options, than puts

Call options by funds: $2.69M | Put options by funds: $6M

Holders
115
Holders Change
+115
Holders Change %
–
% of All Funds
3.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
115
Increased
–
Reduced
–
Closed
–
Calls
$2.69M
Puts
$6M
Net Calls
-$3.31M
Net Calls Change
-$3.31M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
California State Teachers Retirement System (CalSTRS)
51
California State Teachers Retirement System (CalSTRS)
California
$924K +$957K +29,152 New
PAM
52
Panagora Asset Management
Massachusetts
$913K +$946K +28,793 New
MSTVIM
53
Messner & Smith Theme Value Investment Management
California
$903K +$936K +28,484 New
SO
54
STRS Ohio
Ohio
$847K +$877K +26,700 New
Prudential Financial
55
Prudential Financial
New Jersey
$806K +$835K +25,430 New
TG
56
TCW Group
California
$743K +$770K +23,445 New
BG
57
BlackRock Group
United Kingdom
$687K +$711K +21,661 New
William Blair & Company
58
William Blair & Company
Illinois
$667K +$691K +21,050 New
RhumbLine Advisers
59
RhumbLine Advisers
Massachusetts
$614K +$636K +19,363 New
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$591K +$612K +18,644 New
Dimensional Fund Advisors
61
Dimensional Fund Advisors
Texas
$578K +$599K +18,226 New
Nomura Holdings
62
Nomura Holdings
Japan
$566K +$583K +17,752 New
JP Morgan Chase
63
JP Morgan Chase
New York
$546K +$565K +17,203 New
Arrowstreet Capital
64
Arrowstreet Capital
Massachusetts
$543K +$562K +17,115 New
New York State Common Retirement Fund
65
New York State Common Retirement Fund
New York
$534K +$553K +16,840 New
Swiss National Bank
66
Swiss National Bank
Switzerland
$520K +$539K +16,400 New
ProShare Advisors
67
ProShare Advisors
Maryland
$514K +$532K +16,205 New
MAM
68
Martingale Asset Management
Massachusetts
$499K +$516K +15,713 New
MLICM
69
Metropolitan Life Insurance Company (MetLife)
New York
$444K +$460K +13,999 New
Axa
70
Axa
France
$433K +$448K +13,646 New
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$430K +$446K +13,570 New
AIG
72
American International Group
New York
$414K +$429K +13,052 New
SIM
73
Spark Investment Management
New York
$402K +$417K +12,700 New
NFA
74
Nationwide Fund Advisors
Ohio
$393K +$407K +12,392 New
SCM
75
Stonebridge Capital Management
California
$392K +$406K +12,365 New
1 2
3
4 5

GHDX Hedge Fund Activity: Q2 2013 in Review

115 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q2 2013, worth a combined $858M.

Buyers outnumbered sellers: 115 funds opened new GHDX positions and 0 closed out — a net gain of 115 holders — while 0 added to existing stakes and 0 trimmed.

  • 115 institutional investors held Genomic Health, Inc. (GHDX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $858M of Genomic Health, Inc. stock for Q2 2013.
  • 115 funds opened new Genomic Health, Inc. positions in Q2 2013 and 0 closed out, a net change of +115 holders.

Based on aggregated 13F filings for Q2 2013.